APO Research

APO RESEARCH · REPORT

Isoniazid Tablets

Selected research

Industry Research

Isoniazid Tablets Industry Research Report 2026

Market perspective

The global Isoniazid Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Isoniazid Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Isoniazid Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Isoniazid Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Isoniazid Tablets include Yunpeng Pharmaceutical Group Co., Ltd., Tonghua Baishan Pharmaceutical Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd., Sichuan Deyuan Pharmaceutical Group Co., Ltd., Sancai Shiqi Pharmaceutical Co., Ltd., Jiangxi Haiersi Pharmaceutical Co., Ltd., Jichuang Pharmaceutical Group Co., Ltd., Hunan Xinhui Pharmaceutical Co., Ltd. and Hunan Shentaichun Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Isoniazid Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Isoniazid Tablets Market by Company

Yunpeng Pharmaceutical Group Co., Ltd.

Tonghua Baishan Pharmaceutical Co., Ltd.

Tiansheng Pharmaceutical Group Co., Ltd.

Sichuan Deyuan Pharmaceutical Group Co., Ltd.

Sancai Shiqi Pharmaceutical Co., Ltd.

Jiangxi Haiersi Pharmaceutical Co., Ltd.

Jichuang Pharmaceutical Group Co., Ltd.

Hunan Xinhui Pharmaceutical Co., Ltd.

Hunan Shentaichun Pharmaceutical Co., Ltd.

Hunan Kangerjia Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Erkang Pharmaceutical Co., Ltd.

Hubei Renyue Pharmaceutical Co., Ltd.

Hubei Hendi Pharmaceutical Co., Ltd.

Hebei Changtian Pharmaceutical Co., Ltd.

Hebei Tiancheng Pharmaceutical Co., Ltd.

Hangzhou Minsheng Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Pharmaceutical Factory

Sinopharm Guorui Pharmaceutical Co., Ltd.

Guilin Nanyao Co., Ltd.

Guangdong Xinfeng Pharmaceutical Co., Ltd.

Isoniazid Tablets Segment by Type

50mg

100mg

Isoniazid Tablets Segment by Application

Hospital

Clinic

Other

Isoniazid Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isoniazid Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isoniazid Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isoniazid Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Isoniazid Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Isoniazid Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Isoniazid Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Isoniazid Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Isoniazid Tablets Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Isoniazid Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Isoniazid Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Isoniazid Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Isoniazid Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Isoniazid Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Isoniazid Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Isoniazid Tablets, Product Type & Application Table 14. Global Isoniazid Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Isoniazid Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Yunpeng Pharmaceutical Group Co., Ltd. Company Information Table 19. Yunpeng Pharmaceutical Group Co., Ltd. Business Overview Table 20. Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 22. Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments Table 23. Tonghua Baishan Pharmaceutical Co., Ltd. Company Information Table 24. Tonghua Baishan Pharmaceutical Co., Ltd. Business Overview Table 25. Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 27. Tonghua Baishan Pharmaceutical Co., Ltd. Recent Developments Table 28. Tiansheng Pharmaceutical Group Co., Ltd. Company Information Table 29. Tiansheng Pharmaceutical Group Co., Ltd. Business Overview Table 30. Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 32. Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments Table 33. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information Table 34. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview Table 35. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 37. Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments Table 38. Sancai Shiqi Pharmaceutical Co., Ltd. Company Information Table 39. Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview Table 40. Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 42. Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments Table 43. Jiangxi Haiersi Pharmaceutical Co., Ltd. Company Information Table 44. Jiangxi Haiersi Pharmaceutical Co., Ltd. Business Overview Table 45. Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 47. Jiangxi Haiersi Pharmaceutical Co., Ltd. Recent Developments Table 48. Jichuang Pharmaceutical Group Co., Ltd. Company Information Table 49. Jichuang Pharmaceutical Group Co., Ltd. Business Overview Table 50. Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio Table 52. Jichuang Pharmaceutical Group Co., Ltd. Recent Developments Table 53. Hunan Xinhui Pharmaceutical Co., Ltd. Company Information Table 54. Hunan Xinhui Pharmaceutical Co., Ltd. Business Overview Table 55. Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 57. Hunan Xinhui Pharmaceutical Co., Ltd. Recent Developments Table 58. Hunan Shentaichun Pharmaceutical Co., Ltd. Company Information Table 59. Hunan Shentaichun Pharmaceutical Co., Ltd. Business Overview Table 60. Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 62. Hunan Shentaichun Pharmaceutical Co., Ltd. Recent Developments Table 63. Hunan Kangerjia Pharmaceutical Co., Ltd. Company Information Table 64. Hunan Kangerjia Pharmaceutical Co., Ltd. Business Overview Table 65. Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 67. Hunan Kangerjia Pharmaceutical Co., Ltd. Recent Developments Table 68. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 69. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 70. Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 72. Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments Table 73. Hunan Erkang Pharmaceutical Co., Ltd. Company Information Table 74. Hunan Erkang Pharmaceutical Co., Ltd. Business Overview Table 75. Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 77. Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments Table 78. Hubei Renyue Pharmaceutical Co., Ltd. Company Information Table 79. Hubei Renyue Pharmaceutical Co., Ltd. Business Overview Table 80. Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 82. Hubei Renyue Pharmaceutical Co., Ltd. Recent Developments Table 83. Hubei Hendi Pharmaceutical Co., Ltd. Company Information Table 84. Hubei Hendi Pharmaceutical Co., Ltd. Business Overview Table 85. Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 87. Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments Table 88. Hebei Changtian Pharmaceutical Co., Ltd. Company Information Table 89. Hebei Changtian Pharmaceutical Co., Ltd. Business Overview Table 90. Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 92. Hebei Changtian Pharmaceutical Co., Ltd. Recent Developments Table 93. Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information Table 94. Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview Table 95. Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 97. Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments Table 98. Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information Table 99. Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview Table 100. Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 102. Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments Table 103. Harbin Pharmaceutical Group Pharmaceutical Factory Company Information Table 104. Harbin Pharmaceutical Group Pharmaceutical Factory Business Overview Table 105. Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Product Portfolio Table 107. Harbin Pharmaceutical Group Pharmaceutical Factory Recent Developments Table 108. Sinopharm Guorui Pharmaceutical Co., Ltd. Company Information Table 109. Sinopharm Guorui Pharmaceutical Co., Ltd. Business Overview Table 110. Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 112. Sinopharm Guorui Pharmaceutical Co., Ltd. Recent Developments Table 113. Guilin Nanyao Co., Ltd. Company Information Table 114. Guilin Nanyao Co., Ltd. Business Overview Table 115. Guilin Nanyao Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Guilin Nanyao Co., Ltd. Isoniazid Tablets Product Portfolio Table 117. Guilin Nanyao Co., Ltd. Recent Developments Table 118. Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information Table 119. Guangdong Xinfeng Pharmaceutical Co., Ltd. Business Overview Table 120. Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio Table 122. Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Developments Table 123. Global Isoniazid Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 124. Global Isoniazid Tablets Sales by Region (2021-2026) & (K Units) Table 125. Global Isoniazid Tablets Sales Market Share by Region (2021-2026) Table 126. Global Isoniazid Tablets Sales by Region (2027-2032) & (K Units) Table 127. Global Isoniazid Tablets Sales Market Share by Region (2027-2032) Table 128. Global Isoniazid Tablets Revenue by Region (2021-2026) & (US$ Million) Table 129. Global Isoniazid Tablets Revenue Market Share by Region (2021-2026) Table 130. Global Isoniazid Tablets Revenue by Region (2027-2032) & (US$ Million) Table 131. Global Isoniazid Tablets Revenue Market Share by Region (2027-2032) Table 132. North America Isoniazid Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. North America Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 134. North America Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 135. North America Isoniazid Tablets Revenue by Country (2021-2026) & (US$ Million) Table 136. North America Isoniazid Tablets Revenue by Country (2027-2032) & (US$ Million) Table 137. Europe Isoniazid Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Europe Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 139. Europe Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 140. Europe Isoniazid Tablets Revenue by Country (2021-2026) & (US$ Million) Table 141. Europe Isoniazid Tablets Revenue by Country (2027-2032) & (US$ Million) Table 142. Asia Pacific Isoniazid Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Asia Pacific Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 144. Asia Pacific Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 145. Asia Pacific Isoniazid Tablets Revenue by Country (2021-2026) & (US$ Million) Table 146. Asia Pacific Isoniazid Tablets Revenue by Country (2027-2032) & (US$ Million) Table 147. South America Isoniazid Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. South America Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 149. South America Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 150. South America Isoniazid Tablets Revenue by Country (2021-2026) & (US$ Million) Table 151. South America Isoniazid Tablets Revenue by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Isoniazid Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Middle East and Africa Isoniazid Tablets Sales by Country (2021-2026) & (K Units) Table 154. Middle East and Africa Isoniazid Tablets Sales by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Isoniazid Tablets Revenue by Country (2021-2026) & (US$ Million) Table 156. Middle East and Africa Isoniazid Tablets Revenue by Country (2027-2032) & (US$ Million) Table 157. Global Isoniazid Tablets Sales by Type (2021-2026) & (K Units) Table 158. Global Isoniazid Tablets Sales by Type (2027-2032) & (K Units) Table 159. Global Isoniazid Tablets Sales Market Share by Type (2021-2026) Table 160. Global Isoniazid Tablets Sales Market Share by Type (2027-2032) Table 161. Global Isoniazid Tablets Revenue by Type (2021-2026) & (US$ Million) Table 162. Global Isoniazid Tablets Revenue by Type (2027-2032) & (US$ Million) Table 163. Global Isoniazid Tablets Revenue Market Share by Type (2021-2026) Table 164. Global Isoniazid Tablets Revenue Market Share by Type (2027-2032) Table 165. Global Isoniazid Tablets Price by Type (2021-2026) & (US$/Unit) Table 166. Global Isoniazid Tablets Price by Type (2027-2032) & (US$/Unit) Table 167. Global Isoniazid Tablets Sales by Application (2021-2026) & (K Units) Table 168. Global Isoniazid Tablets Sales by Application (2027-2032) & (K Units) Table 169. Global Isoniazid Tablets Sales Market Share by Application (2021-2026) Table 170. Global Isoniazid Tablets Sales Market Share by Application (2027-2032) Table 171. Global Isoniazid Tablets Revenue by Application (2021-2026) & (US$ Million) Table 172. Global Isoniazid Tablets Revenue by Application (2027-2032) & (US$ Million) Table 173. Global Isoniazid Tablets Revenue Market Share by Application (2021-2026) Table 174. Global Isoniazid Tablets Revenue Market Share by Application (2027-2032) Table 175. Global Isoniazid Tablets Price by Application (2021-2026) & (US$/Unit) Table 176. Global Isoniazid Tablets Price by Application (2027-2032) & (US$/Unit) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Isoniazid Tablets Distributors List Table 180. Isoniazid Tablets Customers List Table 181. Isoniazid Tablets Industry Trends Table 182. Isoniazid Tablets Industry Drivers Table 183. Isoniazid Tablets Industry Restraints Table 184. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Isoniazid Tablets Product Image Figure 5. Global Isoniazid Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Isoniazid Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Isoniazid Tablets Sales (2021-2032) & (K Units) Figure 8. Global Isoniazid Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. 50mg Product Image Figure 10. 100mg Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Isoniazid Tablets Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Isoniazid Tablets, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Isoniazid Tablets Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Isoniazid Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Isoniazid Tablets Sales by Region in 2025 Figure 20. Global Isoniazid Tablets Revenue by Region in 2025 Figure 21. North America Isoniazid Tablets Market Size by Country in 2025 Figure 22. North America Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 23. North America Isoniazid Tablets Revenue Market Share by Country (2021-2032) Figure 24. United States Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Isoniazid Tablets Market Size by Country in 2025 Figure 28. Europe Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 29. Europe Isoniazid Tablets Revenue Market Share by Country (2021-2032) Figure 30. Germany Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Isoniazid Tablets Market Size by Country in 2025 Figure 41. Asia Pacific Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Isoniazid Tablets Revenue Market Share by Country (2021-2032) Figure 43. China Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Isoniazid Tablets Market Size by Country in 2025 Figure 52. South America Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 53. South America Isoniazid Tablets Revenue Market Share by Country (2021-2032) Figure 54. Brazil Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Isoniazid Tablets Market Size by Country in 2025 Figure 59. Middle East and Africa Isoniazid Tablets Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Isoniazid Tablets Revenue Market Share by Country (2021-2032) Figure 61. Egypt Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Isoniazid Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Isoniazid Tablets Sales Market Share by Type (2021-2032) Figure 67. Global Isoniazid Tablets Revenue Market Share by Type (2021-2032) Figure 68. Global Isoniazid Tablets Price (US$/Unit) by Type (2021-2032) Figure 69. Global Isoniazid Tablets Sales Market Share by Application (2021-2032) Figure 70. Global Isoniazid Tablets Revenue Market Share by Application (2021-2032) Figure 71. Global Isoniazid Tablets Price (US$/Unit) by Application (2021-2032) Figure 72. Isoniazid Tablets Value Chain Figure 73. Isoniazid Tablets Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Isoniazid Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • 50mg
  • 100mg
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yunpeng Pharmaceutical Group Co., Ltd.
  • Tonghua Baishan Pharmaceutical Co., Ltd.
  • Tiansheng Pharmaceutical Group Co., Ltd.
  • Sichuan Deyuan Pharmaceutical Group Co., Ltd.
  • Sancai Shiqi Pharmaceutical Co., Ltd.
  • Jiangxi Haiersi Pharmaceutical Co., Ltd.
  • Jichuang Pharmaceutical Group Co., Ltd.
  • Hunan Xinhui Pharmaceutical Co., Ltd.
  • Hunan Shentaichun Pharmaceutical Co., Ltd.
  • Hunan Kangerjia Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Hunan Erkang Pharmaceutical Co., Ltd.
  • Hubei Renyue Pharmaceutical Co., Ltd.
  • Hubei Hendi Pharmaceutical Co., Ltd.
  • Hebei Changtian Pharmaceutical Co., Ltd.
  • Hebei Tiancheng Pharmaceutical Co., Ltd.
  • Hangzhou Minsheng Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Pharmaceutical Factory
  • Sinopharm Guorui Pharmaceutical Co., Ltd.
  • Guilin Nanyao Co., Ltd.
  • Guangdong Xinfeng Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Isoniazid Tablets Market Size (2021-2032)
  4. 2.2.2 Global Isoniazid Tablets Sales (2021-2032)
  5. 2.2.3 Global Isoniazid Tablets Market Average Price (2021-2032)
  6. 2.3 Isoniazid Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 50mg
  9. 2.3.3 100mg
  10. 2.4 Isoniazid Tablets by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Isoniazid Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Isoniazid Tablets Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Isoniazid Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Isoniazid Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Isoniazid Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Isoniazid Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Isoniazid Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Isoniazid Tablets, Established Date
  9. 3.9 Global Isoniazid Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Yunpeng Pharmaceutical Group Co., Ltd.
  2. 4.1.1 Yunpeng Pharmaceutical Group Co., Ltd. Company Information
  3. 4.1.2 Yunpeng Pharmaceutical Group Co., Ltd. Business Overview
  4. 4.1.3 Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Yunpeng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  6. 4.1.5 Yunpeng Pharmaceutical Group Co., Ltd. Recent Developments
  7. 4.2 Tonghua Baishan Pharmaceutical Co., Ltd.
  8. 4.2.1 Tonghua Baishan Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Tonghua Baishan Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Tonghua Baishan Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  12. 4.2.5 Tonghua Baishan Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Tiansheng Pharmaceutical Group Co., Ltd.
  14. 4.3.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
  15. 4.3.2 Tiansheng Pharmaceutical Group Co., Ltd. Business Overview
  16. 4.3.3 Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Tiansheng Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  18. 4.3.5 Tiansheng Pharmaceutical Group Co., Ltd. Recent Developments
  19. 4.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd.
  20. 4.4.1 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Company Information
  21. 4.4.2 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Business Overview
  22. 4.4.3 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  24. 4.4.5 Sichuan Deyuan Pharmaceutical Group Co., Ltd. Recent Developments
  25. 4.5 Sancai Shiqi Pharmaceutical Co., Ltd.
  26. 4.5.1 Sancai Shiqi Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Sancai Shiqi Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sancai Shiqi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  30. 4.5.5 Sancai Shiqi Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Jiangxi Haiersi Pharmaceutical Co., Ltd.
  32. 4.6.1 Jiangxi Haiersi Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Jiangxi Haiersi Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Jiangxi Haiersi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  36. 4.6.5 Jiangxi Haiersi Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Jichuang Pharmaceutical Group Co., Ltd.
  38. 4.7.1 Jichuang Pharmaceutical Group Co., Ltd. Company Information
  39. 4.7.2 Jichuang Pharmaceutical Group Co., Ltd. Business Overview
  40. 4.7.3 Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jichuang Pharmaceutical Group Co., Ltd. Isoniazid Tablets Product Portfolio
  42. 4.7.5 Jichuang Pharmaceutical Group Co., Ltd. Recent Developments
  43. 4.8 Hunan Xinhui Pharmaceutical Co., Ltd.
  44. 4.8.1 Hunan Xinhui Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Hunan Xinhui Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Hunan Xinhui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  48. 4.8.5 Hunan Xinhui Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Hunan Shentaichun Pharmaceutical Co., Ltd.
  50. 4.9.1 Hunan Shentaichun Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Hunan Shentaichun Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hunan Shentaichun Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  54. 4.9.5 Hunan Shentaichun Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Hunan Kangerjia Pharmaceutical Co., Ltd.
  56. 4.10.1 Hunan Kangerjia Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Hunan Kangerjia Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hunan Kangerjia Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  60. 4.10.5 Hunan Kangerjia Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Hunan Hansen Pharmaceutical Co., Ltd.
  62. 4.11.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hunan Hansen Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  66. 4.11.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Hunan Erkang Pharmaceutical Co., Ltd.
  68. 4.12.1 Hunan Erkang Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Hunan Erkang Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hunan Erkang Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  72. 4.12.5 Hunan Erkang Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Hubei Renyue Pharmaceutical Co., Ltd.
  74. 4.13.1 Hubei Renyue Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Hubei Renyue Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Hubei Renyue Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  78. 4.13.5 Hubei Renyue Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Hubei Hendi Pharmaceutical Co., Ltd.
  80. 4.14.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Hubei Hendi Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hubei Hendi Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  84. 4.14.5 Hubei Hendi Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Hebei Changtian Pharmaceutical Co., Ltd.
  86. 4.15.1 Hebei Changtian Pharmaceutical Co., Ltd. Company Information
  87. 4.15.2 Hebei Changtian Pharmaceutical Co., Ltd. Business Overview
  88. 4.15.3 Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Hebei Changtian Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  90. 4.15.5 Hebei Changtian Pharmaceutical Co., Ltd. Recent Developments
  91. 4.16 Hebei Tiancheng Pharmaceutical Co., Ltd.
  92. 4.16.1 Hebei Tiancheng Pharmaceutical Co., Ltd. Company Information
  93. 4.16.2 Hebei Tiancheng Pharmaceutical Co., Ltd. Business Overview
  94. 4.16.3 Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Hebei Tiancheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  96. 4.16.5 Hebei Tiancheng Pharmaceutical Co., Ltd. Recent Developments
  97. 4.17 Hangzhou Minsheng Pharmaceutical Co., Ltd.
  98. 4.17.1 Hangzhou Minsheng Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Hangzhou Minsheng Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Hangzhou Minsheng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  102. 4.17.5 Hangzhou Minsheng Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Harbin Pharmaceutical Group Pharmaceutical Factory
  104. 4.18.1 Harbin Pharmaceutical Group Pharmaceutical Factory Company Information
  105. 4.18.2 Harbin Pharmaceutical Group Pharmaceutical Factory Business Overview
  106. 4.18.3 Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Harbin Pharmaceutical Group Pharmaceutical Factory Isoniazid Tablets Product Portfolio
  108. 4.18.5 Harbin Pharmaceutical Group Pharmaceutical Factory Recent Developments
  109. 4.19 Sinopharm Guorui Pharmaceutical Co., Ltd.
  110. 4.19.1 Sinopharm Guorui Pharmaceutical Co., Ltd. Company Information
  111. 4.19.2 Sinopharm Guorui Pharmaceutical Co., Ltd. Business Overview
  112. 4.19.3 Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Sinopharm Guorui Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  114. 4.19.5 Sinopharm Guorui Pharmaceutical Co., Ltd. Recent Developments
  115. 4.20 Guilin Nanyao Co., Ltd.
  116. 4.20.1 Guilin Nanyao Co., Ltd. Company Information
  117. 4.20.2 Guilin Nanyao Co., Ltd. Business Overview
  118. 4.20.3 Guilin Nanyao Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Guilin Nanyao Co., Ltd. Isoniazid Tablets Product Portfolio
  120. 4.20.5 Guilin Nanyao Co., Ltd. Recent Developments
  121. 4.21 Guangdong Xinfeng Pharmaceutical Co., Ltd.
  122. 4.21.1 Guangdong Xinfeng Pharmaceutical Co., Ltd. Company Information
  123. 4.21.2 Guangdong Xinfeng Pharmaceutical Co., Ltd. Business Overview
  124. 4.21.3 Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Guangdong Xinfeng Pharmaceutical Co., Ltd. Isoniazid Tablets Product Portfolio
  126. 4.21.5 Guangdong Xinfeng Pharmaceutical Co., Ltd. Recent Developments
5 Global Isoniazid Tablets Market Scenario by Region
  1. 5.1 Global Isoniazid Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Isoniazid Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Isoniazid Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Isoniazid Tablets Sales by Region: 2027-2032
  5. 5.3 Global Isoniazid Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Isoniazid Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Isoniazid Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Isoniazid Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Isoniazid Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Isoniazid Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Isoniazid Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Isoniazid Tablets Market Facts & Figures by Country
  16. 5.5.1 Europe Isoniazid Tablets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Isoniazid Tablets Sales by Country (2021-2032)
  18. 5.5.3 Europe Isoniazid Tablets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Isoniazid Tablets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Isoniazid Tablets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Isoniazid Tablets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Isoniazid Tablets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Isoniazid Tablets Market Facts & Figures by Country
  41. 5.7.1 South America Isoniazid Tablets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Isoniazid Tablets Sales by Country (2021-2032)
  43. 5.7.3 South America Isoniazid Tablets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Isoniazid Tablets Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Isoniazid Tablets Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Isoniazid Tablets Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Isoniazid Tablets Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Isoniazid Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Isoniazid Tablets Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Isoniazid Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Isoniazid Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Isoniazid Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Isoniazid Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Isoniazid Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Isoniazid Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Isoniazid Tablets Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Isoniazid Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Isoniazid Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Isoniazid Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Isoniazid Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Isoniazid Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Isoniazid Tablets Value Chain Analysis
  2. 8.1.1 Isoniazid Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Isoniazid Tablets Production Mode & Process
  5. 8.2 Isoniazid Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Isoniazid Tablets Distributors
  8. 8.2.3 Isoniazid Tablets Customers
9 Global Isoniazid Tablets Analyzing Market Dynamics
  1. 9.1 Isoniazid Tablets Industry Trends
  2. 9.2 Isoniazid Tablets Industry Drivers
  3. 9.3 Isoniazid Tablets Industry Opportunities and Challenges
  4. 9.4 Isoniazid Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research